Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter

Edward W. Inscho, Anthony K. Cook, R. Clinton Webb, Li Ming Jin

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Preglomerular resistance is regulated by calcium influx- and mobilization-dependent mechanisms; however, the role of Rho-kinase in calcium sensitization in the intact kidney has not been carefully examined. Experiments were performed to test the hypothesis that Rho-kinase inhibition blunts pressure-mediated afferent arteriolar autoregulatory behavior and vasoconstrictor responses evoked by angiotensin II and P2X1 receptor activation. Rat kidneys were studied in vitro using the blood-perfused juxtamedullary nephron technique. Autoregulatory behavior was assessed before and during Rho-kinase inhibition with Y-27632 (1.0 μM; n = 5). Control diameter averaged 14.3 ± 0.8 μm and increased to 18.1 ± 0.9 μm (P < 0.05) during Y-27632 treatment. In the continued presence of Y-27632, reducing perfusion pressure to 65 mmHg slightly increased diameter to 18.7 ± 1.0 μm. Subsequent pressure increases to 130 and 160 mmHg yielded afferent arteriolar diameters of 17.5 ± 0.8 and 16.6 ± 0.6 μm (P < 0.05). This 11% decline in diameter is significantly smaller than the 40% decrease obtained in untreated kidneys. The inhibitory effects of Y-27632 on autoregulatory behavior were concentration dependent. Angiotensin II responses were blunted by Y-27632. Angiotensin II (1.0 nM) reduced afferent diameter by 17 ± 1% in untreated arterioles and by 6 ± 2% during exposure to Y-27632. The P2X1 receptor agonist, α, β-methylene ATP, reduced afferent arteriolar diameter by 8 ± 1% but this response was eliminated during exposure to Y-27632. Western blot analysis confirms expression of the Rho-kinase signaling pathway. Thus, Rho-kinase may be important in pressure-mediated autoregulatory adjustments in preglomerular resistance and responsiveness to angiotensin II and autoregulatory P2X 1 receptor agonists.

Original languageEnglish (US)
Pages (from-to)F590-F597
JournalAmerican Journal of Physiology - Renal Physiology
Volume296
Issue number3
DOIs
StatePublished - Mar 1 2009

Fingerprint

Social Adjustment
rho-Associated Kinases
Pressure
Purinergic P2X1 Receptors
Angiotensin II
Kidney
Calcium
Angiotensin Receptors
Nephrons
Arterioles
Vasoconstrictor Agents
Y 27632
Inhibition (Psychology)
Perfusion
Adenosine Triphosphate
Western Blotting

Keywords

  • ATP
  • Autoregulation
  • P2 receptors
  • P2X receptors
  • Y-27632

ASJC Scopus subject areas

  • Physiology
  • Urology

Cite this

Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter. / Inscho, Edward W.; Cook, Anthony K.; Webb, R. Clinton; Jin, Li Ming.

In: American Journal of Physiology - Renal Physiology, Vol. 296, No. 3, 01.03.2009, p. F590-F597.

Research output: Contribution to journalArticle

@article{62ce8398e120455da8666335c19073cf,
title = "Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter",
abstract = "Preglomerular resistance is regulated by calcium influx- and mobilization-dependent mechanisms; however, the role of Rho-kinase in calcium sensitization in the intact kidney has not been carefully examined. Experiments were performed to test the hypothesis that Rho-kinase inhibition blunts pressure-mediated afferent arteriolar autoregulatory behavior and vasoconstrictor responses evoked by angiotensin II and P2X1 receptor activation. Rat kidneys were studied in vitro using the blood-perfused juxtamedullary nephron technique. Autoregulatory behavior was assessed before and during Rho-kinase inhibition with Y-27632 (1.0 μM; n = 5). Control diameter averaged 14.3 ± 0.8 μm and increased to 18.1 ± 0.9 μm (P < 0.05) during Y-27632 treatment. In the continued presence of Y-27632, reducing perfusion pressure to 65 mmHg slightly increased diameter to 18.7 ± 1.0 μm. Subsequent pressure increases to 130 and 160 mmHg yielded afferent arteriolar diameters of 17.5 ± 0.8 and 16.6 ± 0.6 μm (P < 0.05). This 11{\%} decline in diameter is significantly smaller than the 40{\%} decrease obtained in untreated kidneys. The inhibitory effects of Y-27632 on autoregulatory behavior were concentration dependent. Angiotensin II responses were blunted by Y-27632. Angiotensin II (1.0 nM) reduced afferent diameter by 17 ± 1{\%} in untreated arterioles and by 6 ± 2{\%} during exposure to Y-27632. The P2X1 receptor agonist, α, β-methylene ATP, reduced afferent arteriolar diameter by 8 ± 1{\%} but this response was eliminated during exposure to Y-27632. Western blot analysis confirms expression of the Rho-kinase signaling pathway. Thus, Rho-kinase may be important in pressure-mediated autoregulatory adjustments in preglomerular resistance and responsiveness to angiotensin II and autoregulatory P2X 1 receptor agonists.",
keywords = "ATP, Autoregulation, P2 receptors, P2X receptors, Y-27632",
author = "Inscho, {Edward W.} and Cook, {Anthony K.} and Webb, {R. Clinton} and Jin, {Li Ming}",
year = "2009",
month = "3",
day = "1",
doi = "10.1152/ajprenal.90703.2008",
language = "English (US)",
volume = "296",
pages = "F590--F597",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter

AU - Inscho, Edward W.

AU - Cook, Anthony K.

AU - Webb, R. Clinton

AU - Jin, Li Ming

PY - 2009/3/1

Y1 - 2009/3/1

N2 - Preglomerular resistance is regulated by calcium influx- and mobilization-dependent mechanisms; however, the role of Rho-kinase in calcium sensitization in the intact kidney has not been carefully examined. Experiments were performed to test the hypothesis that Rho-kinase inhibition blunts pressure-mediated afferent arteriolar autoregulatory behavior and vasoconstrictor responses evoked by angiotensin II and P2X1 receptor activation. Rat kidneys were studied in vitro using the blood-perfused juxtamedullary nephron technique. Autoregulatory behavior was assessed before and during Rho-kinase inhibition with Y-27632 (1.0 μM; n = 5). Control diameter averaged 14.3 ± 0.8 μm and increased to 18.1 ± 0.9 μm (P < 0.05) during Y-27632 treatment. In the continued presence of Y-27632, reducing perfusion pressure to 65 mmHg slightly increased diameter to 18.7 ± 1.0 μm. Subsequent pressure increases to 130 and 160 mmHg yielded afferent arteriolar diameters of 17.5 ± 0.8 and 16.6 ± 0.6 μm (P < 0.05). This 11% decline in diameter is significantly smaller than the 40% decrease obtained in untreated kidneys. The inhibitory effects of Y-27632 on autoregulatory behavior were concentration dependent. Angiotensin II responses were blunted by Y-27632. Angiotensin II (1.0 nM) reduced afferent diameter by 17 ± 1% in untreated arterioles and by 6 ± 2% during exposure to Y-27632. The P2X1 receptor agonist, α, β-methylene ATP, reduced afferent arteriolar diameter by 8 ± 1% but this response was eliminated during exposure to Y-27632. Western blot analysis confirms expression of the Rho-kinase signaling pathway. Thus, Rho-kinase may be important in pressure-mediated autoregulatory adjustments in preglomerular resistance and responsiveness to angiotensin II and autoregulatory P2X 1 receptor agonists.

AB - Preglomerular resistance is regulated by calcium influx- and mobilization-dependent mechanisms; however, the role of Rho-kinase in calcium sensitization in the intact kidney has not been carefully examined. Experiments were performed to test the hypothesis that Rho-kinase inhibition blunts pressure-mediated afferent arteriolar autoregulatory behavior and vasoconstrictor responses evoked by angiotensin II and P2X1 receptor activation. Rat kidneys were studied in vitro using the blood-perfused juxtamedullary nephron technique. Autoregulatory behavior was assessed before and during Rho-kinase inhibition with Y-27632 (1.0 μM; n = 5). Control diameter averaged 14.3 ± 0.8 μm and increased to 18.1 ± 0.9 μm (P < 0.05) during Y-27632 treatment. In the continued presence of Y-27632, reducing perfusion pressure to 65 mmHg slightly increased diameter to 18.7 ± 1.0 μm. Subsequent pressure increases to 130 and 160 mmHg yielded afferent arteriolar diameters of 17.5 ± 0.8 and 16.6 ± 0.6 μm (P < 0.05). This 11% decline in diameter is significantly smaller than the 40% decrease obtained in untreated kidneys. The inhibitory effects of Y-27632 on autoregulatory behavior were concentration dependent. Angiotensin II responses were blunted by Y-27632. Angiotensin II (1.0 nM) reduced afferent diameter by 17 ± 1% in untreated arterioles and by 6 ± 2% during exposure to Y-27632. The P2X1 receptor agonist, α, β-methylene ATP, reduced afferent arteriolar diameter by 8 ± 1% but this response was eliminated during exposure to Y-27632. Western blot analysis confirms expression of the Rho-kinase signaling pathway. Thus, Rho-kinase may be important in pressure-mediated autoregulatory adjustments in preglomerular resistance and responsiveness to angiotensin II and autoregulatory P2X 1 receptor agonists.

KW - ATP

KW - Autoregulation

KW - P2 receptors

KW - P2X receptors

KW - Y-27632

UR - http://www.scopus.com/inward/record.url?scp=66049160044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66049160044&partnerID=8YFLogxK

U2 - 10.1152/ajprenal.90703.2008

DO - 10.1152/ajprenal.90703.2008

M3 - Article

C2 - 19129253

AN - SCOPUS:66049160044

VL - 296

SP - F590-F597

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 3

ER -